Hongnan Jin

IL-17E, a proinflammatory cytokine, has antitumor efficacy against several tumor types in vivo

Tania Benatar, Ming Cao, Yoon Lee et al. · Cancer Immunology Immunotherapy · 2009 · 100 citations · Full text

Inflammation, Several Tumor Types, Immune Evasion +10

GTI-2040, an antisense agent targeting the small subunit component (R2) of human ribonucleotide reductase, shows potent antitumor activity against a variety of tumors.

Yoon Lee, Aikaterini Vassilakos, Ningping Feng et al. · PubMed · 2003 · 92 citations

Chemoprevention Strategy, Human Ribonucleotide Reductase, Pathology +16

Virulizin® induces production of IL-17E to enhance antitumor activity by recruitment of eosinophils into tumors

Tania Benatar, Ming Cao, Hui Li et al. · Cancer Immunology Immunotherapy · 2008 · 52 citations · Full text

Inflammation, Cytokine, Antitumor Activity +5

Adenovirus-mediated ribonucleotide reductase R1 gene therapy of human colon adenocarcinoma.

Ming‐Yu Cao, Yoon Seong Lee, Ningping Feng et al. · PubMed · 2003 · 36 citations

Tumor Biology, Ribonucleotide Reductase, Human Colon Adenocarcinoma +15

A novel small molecule with potent anticancer activity inhibits cell growth by modulating intracellular labile zinc homeostasis

Mario Huesca, Lisa Lock, Aye Aye Khine et al. · Molecular Cancer Therapeutics · 2009 · 31 citations